Daclizumab Subcutaneous and Tetracycline Mucous membrane, oral
Determining the interaction of Daclizumab Subcutaneous and Tetracycline Mucous membrane, oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: tetracycline
Brand name: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500
Synonyms: Tetracycline, Tetracycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Tetracycline Topical application
- Daclizumab Subcutaneous-Tetrahydrozoline (Nasal)
- Daclizumab Subcutaneous-Tetrahydrozoline and zinc ophthalmic
- Daclizumab Subcutaneous-Tetrahydrozoline Hydrochloride
- Daclizumab Subcutaneous-Tetrahydrozoline ophthalmic
- Daclizumab Subcutaneous-Tetrofosmin
- Tetracycline Mucous membrane, oral-Dacogen
- Tetracycline Mucous membrane, oral-Dacomitinib
- Tetracycline Mucous membrane, oral-Dactinomycin
- Tetracycline Mucous membrane, oral-Dactinomycin Injection
- Tetracycline Mucous membrane, oral-Dactinomycin Intravenous
- Tetracycline Mucous membrane, oral-Daklinza